Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study

Nephrology

Volumn 20, Issue 7, 2015, Pages 474-484

  Wang, Shengfeng ^a   Chen, Ru ^a   Liu, Qing ^b   Shu, Zheng ^a   Zhan, Siyan ^a   Li, Liming ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BROWN UNIVERSITY   (United States)

Author keywords

awareness; chronic kidney disease; CKD EPI eGFRcr cys equation; middle aged and elderly; prevalence; treatment

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGE; AGED; ATTITUDE TO ILLNESS; AWARENESS; CHINA; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; ELDERLY CARE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RURAL POPULATION; URBAN POPULATION; ATTITUDE TO HEALTH; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

AGED; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84930698947     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12449     Document Type: Conference Paper

References (48)

1. Coresh J,. A decade after the KDOQI CKD guidelines: Impact on research. Am. J. Kidney Dis. 2012; 60: 701-704.
2. Roderick P,. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
3. KDIGO. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 2013; 3: 81-90.
4. Zhang QL, Rothenbacher D,. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008; 8: 117.
5. Tonelli M, Riella M,. Chronic kidney disease and the ageing population. Lancet 2014; 383: 1278-1279.
6. China Statistics Press. Tabulation on the 2010 Population Census of the People's Republic of China, Vol. 2015. Beijing, China: China Statistics Press, 2010.
7. WHO. Projections of mortality and causes of death, 2015 and 2030. 2012.
8. Liu Z,. Nephrology in China. Nat. Rev. Nephrol. 2013; 9: 523-528.
9. Zuo L, Wang M,. Current burden and probable increasing incidence of ESRD in China. Clin. Nephrol. 2010; 74: S20-22.
10. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: A population study from Beijing. Am. J. Kidney Dis. 2008; 51: 373-384.
11. Chen W, Chen W, Wang H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol. Dial. Transplant. 2009; 24: 1205-1212.
12. Chen J, Wildman RP, Gu D, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005; 68: 2837-2845.
13. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012; 379: 815-822.
14. Cao Y, Li W, Yang G, Liu Y, Li X,. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: A comparison between 1990-1991 and 2009-2010. Int. Urol. Nephrol. 2012; 44: 1269-1276.
15. Liu CK, Lyass A, Massaro JM, D'Agostino RS, Fox CS, Murabito JM,. Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: The Framingham Offspring Study. J. Gerontol. A. Biol Sci. Med Sci 2014; 69: 301-307.
16. Zhang M, Chen Y, Tang L, et al. Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population. Nephrol. Dial. Transplant. 2014; 29: 580-586.
17. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 2012; 367: 20-29.
18. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G,. Cohort profile: The China Health and Retirement Longitudinal Study (CHARLS). Int. J. Epidemiol. 2014; 43: 61-68.
19. Feng XL, Pang M, Beard J,. Health system strengthening and hypertension awareness, treatment and control: Data from the China Health and Retirement Longitudinal Study. Bull. World Health Organ. 2014; 92: 29-41.
20. Research CCFE. China health and retirement longitudinal study: 2011-2012 national baseline blood data users' guide. 2014.
21. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572. Published correction appears in JAMA 2003; 290: 197.
22. Association AD,. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36: S67-74.
23. Chen C, Lu FC,. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed. Environ. Sci. 2004; 17 (Suppl): 1-36.
24. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid AK,. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia: Health Communication Australia, 2000.
25. The Chinese professional groups for the diagnosis and treatment of cardiovascular disease combined asymptomatic hyperuricemia.The diagnosis and treatment advice of cardiovascular disease combined asymptomatic hyperuricemia (second edition). Chin. J. Cardiovasc. Rev. 2012; 10: 241-249.
26. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604-612.
27. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006; 17: 2937.
28. Zhu Y, Ye X, Zhu B, et al. Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations. PLoS ONE 2014; 9: e84688.
29. U. S. Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
30. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038.
31. Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118: 2679-2686.
32. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2012: Key Indicators of Well-Being. Federal Interagency Forum on Aging-Related Statistics. Washington, DC: U.S. Government Printing Office, 2014. June 2012.
33. Fouque D, Pelletier S, Mafra D, Chauveau P,. Nutrition and chronic kidney disease. Kidney Int. 2011; 80: 348-357.
34. Muneyuki T, Sugawara H, Suwa K, et al. A community-based cross-sectional and longitudinal study uncovered asymptomatic proteinuria in Japanese adults with low body weight. Kidney Int. 2013; 84: 1254-1261.
35. Collins AJ, Gilbertson DT, Snyder JJ, Chen SC, Foley RN,. Chronic kidney disease awareness, screening and prevention: Rationale for the design of a public education program. Nephrology (Carlton) 2010; 15 (Suppl 2): 37-42.
36. Wang J, Zhang L, Wang F, Liu L, Wang H,. Prevalence, awareness, treatment, and control of hypertension in China: Results from a national survey. Am. J. Hypertens. 2014; 27: 1355-1361.
37. Yang ZY, Yang Z, Zhu L, Qiu C,. Human behaviors determine health: Strategic thoughts on the prevention of chronic non-communicable diseases in China. Int. J. Behav. Med. 2011; 18: 295-301.
38. Wang H, Zhang L, Zuo L,. A decade after the KDOQI CKD guidelines: A perspective from China. Am. J. Kidney Dis. 2012; 60: 727-728.
39. Mason J, Khunti K, Stone M, Farooqi A, Carr S,. Educational interventions in kidney disease care: A systematic review of randomized trials. Am. J. Kidney Dis. 2008; 51: 933-951.
40. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2010; 80: 17-28.
41. James MT, Hemmelgarn BR, Tonelli M,. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296-1309.
42. Wen CP, Cheng T, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182.
43. Jha V,. Herbal medicines and chronic kidney disease. Nephrology (Carlton) 2010; 15 (Suppl 2): 10-17.
44. Jones-Burton C, Seliger SL, Scherer RW, et al. Cigarette smoking and incident chronic kidney disease: A systematic review. Am. J. Nephrol. 2007; 27: 342-351.
45. Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P,. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014; 15: 122.
46. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J. Am. Soc. Nephrol. 2003; 14: S131-138.
47. Neugarten J, Acharya A, Silbiger SR,. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J. Am. Soc. Nephrol. 2000; 11: 319-329.
48. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K,. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann. Intern. Med. 2012; 156: 785-795, W-270, W-271, W-272, W-273, W-274, W-275, W-276, W-277, W-278.